Ev. Quadros et al., CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO EPITOPES OF HUMAN TRANSCOBALAMIN-II, Biochemical and biophysical research communications, 222(1), 1996, pp. 149-154
Cellular uptake of cobalamin (Cbl) is mediated by transcobalamin II (T
CII), a Cbl binding protein in the plasma. The TCII-Cbl complex binds
to a cell surface receptor and is internalized by endocytosis. We have
generated monoclonal antibodies (mAbs) to human TCII that can be dist
inguished into three functional types on the basis of interaction with
three different regions of the protein, Type 1: Receptor blocking. Th
is mAb binds holo-TCII and inhibits the cellular uptake of Cbl. Type 2
: Cbl blocking. This mAb binds apo-TCII at or near the Cbl binding dom
ain and inhibits the formation of holo-TCII. Type 3: Precipitating. Th
is mAb binds both holo-TCII and apo-TCII but does not interfere with C
bl binding. Whereas type 1 and type 2 mAb, Following incubation with T
CII-[Co-57]Cbl or apo-TCII, respectively, inhibit the uptake of radio-
labeled Cbl by K562 cells, type 3 mAb has no such activity with either
form of TCII. These properties of type 1 and type mAb that inhibit th
e cellular uptake of Cbl, may serve to induce rapid Cbl deficiency and
provide a model to study the effect of selective Cbl depletion on cel
l division and differentiation as well as on the pathways dependent on
the two Cbl cofactors, methyl-Cbl and 5'-deoxyadenosyl-Cbl. (C) 1996
Academic Press, Inc.